ScholarIQanswers from OpenAlex

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer have?

ScholarIQcitation count

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer has 4,513 citations in the OpenAlex counts ScholarIQ stores.

When was Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer published?

ScholarIQyear

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer has 2010 year in the ScholarIQ index.

What is the open-access status of Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer?

ScholarIQoa status

Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer has closed oa status in the ScholarIQ index.

What is the DOI of Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer?

ScholarIQdoi

The DOI for Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer?

ScholarIQpmid

The PMID for Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer?

ScholarIQopenalex

The OpenAlex for Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial